[ad_1] SHANGHAI, Oct. 11, 2023 /PRNewswire/ — Shanghai Kehua Bio-engineering Co., Ltd (“KHB” or “the Company”, Stock code: 002022.SZ), China’s leading In Vitro Diagnostic (IVD) company has achieved a significant…
[ad_1] SHANGHAI, Oct. 11, 2023 /PRNewswire/ — Shanghai Kehua Bio-engineering Co., Ltd (“KHB” or “the Company”, Stock code: 002022.SZ), China’s leading In Vitro Diagnostic (IVD) company has achieved a significant…